Rezultati - Baker CL

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial od Baker CL, Pietri G

Polni tekst

Risk assessment of readmissions following an initial COPD-related hospitalization od Baker CL, Zou KH, Su J

Polni tekst

Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data od Baker CL, Zou KH, Su J

Polni tekst

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective od Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P

Polni tekst

Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification od Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS

Polni tekst

Adjusting for COPD severity in database research: developing and validating an algorithm od Goossens LMA, Baker CL, Monz BU, Zou KH, Rutten-van Mölken MPMH

Polni tekst

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease od Halpern R, Baker CL, Su J, Woodruff KB, Paulose-Ram R, Porter V, Shah H

Polni tekst

COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members od Pasquale MK, Xu Y, Baker CL, Zou KH, Teeter JG, Renda AM, Davis CC, Lee TC, Bobula J

Polni tekst